Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Pharmosa Biopharm Inc. (6875) Income Statement

Pharmosa Biopharm Inc. Income Statement

Last quarter (Q2 2026), Pharmosa Biopharm Inc.'s total revenue was NT$0.00, a decrease of 100.00% from the same quarter last year. In Q2, Pharmosa Biopharm Inc.'s net income was NT$-100.14M. See Pharmosa Biopharm Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Mar 23Dec 21
NT$ 67.27MNT$ 167.57MNT$ 314.50MNT$ 0.00NT$ 0.00
NT$ -15.75MNT$ 126.90MNT$ 314.50MNT$ 0.00NT$ 0.00
NT$ 387.11MNT$ 345.47MNT$ 317.32MNT$ 271.53MNT$ 259.12M
Depreciation and AmortizationNT$ 31.48MNT$ 25.80MNT$ 23.32MNT$ 12.70MNT$ 11.80M
NT$ -371.37MNT$ -140.38MNT$ 34.63MNT$ -257.08MNT$ -244.13M
NT$ -402.86MNT$ -218.57MNT$ -2.82MNT$ -265.86MNT$ -255.26M
NT$ 19.01MNT$ 51.91MNT$ 11.28MNT$ 5.03MNT$ 2.64M
NT$ -383.85MNT$ -166.65MNT$ 8.46MNT$ -266.51MNT$ -256.48M
NT$ -383.85MNT$ -166.65MNT$ 8.46MNT$ -266.51MNT$ -256.48M
Per Share Metrics
Basic EPSNT$ -2.97NT$ -1.32NT$ 0.07NT$ -2.65NT$ -2.94
Diluted EPSNT$ -2.97NT$ -1.32NT$ 0.07NT$ -2.65NT$ -2.94
Weighted Average Shares Outstanding129.10M126.42M113.22M100.74M87.14M
Weighted Average Shares Outstanding (Diluted)129.10M126.42M113.39M100.74M87.14M

Currency in TWD

Pharmosa Biopharm Inc. Earnings and Revenue History

-800M-400M0400M-600 %-300 %0 %300 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin